Somatostatin-28 1-12
CAS No. 81286-16-0
Somatostatin-28 1-12( 1-12-Somatostatin-28 )
Catalog No. M29957 CAS No. 81286-16-0
Somatostatin-28 (1-12) is a somatostatin fragment which is monitored in brain tissue to track processing of somatostatin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 417 | Get Quote |
|
| 10MG | 705 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSomatostatin-28 1-12
-
NoteResearch use only, not for human use.
-
Brief DescriptionSomatostatin-28 (1-12) is a somatostatin fragment which is monitored in brain tissue to track processing of somatostatin.
-
DescriptionSomatostatin-28 (1-12) is a somatostatin fragment which is monitored in brain tissue to track processing of somatostatin.
-
In Vitro——
-
In Vivo——
-
Synonyms1-12-Somatostatin-28
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number81286-16-0
-
Formula Weight1244.33
-
Molecular FormulaC49H81N17O19S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Artemisinic acid
Artemisinic acid is a major precursor of artemisinin (an antimalaric compound), isolated as the active principles of the medicinal plant Artemisia annua L.
-
14-hydroxylated bras...
14-hydroxylated brassinosteroid
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
Cart
sales@molnova.com